Global Interventional Radiology Market Outlook, 2030

The global Interventional Radiology (IR) market stands as a cornerstone of modern medical imaging and minimally invasive treatments, integrating cutting-edge imaging techniques with precision-guided therapeutic interventions. This market is expanding rapidly, fueled by the increasing need for real-time, image-guided procedures that reduce surgical risks and hospital stays. Interventional radiology is used in various medical fields, including oncology, cardiology, neurology, and vascular medicine, where it enables targeted treatments through catheter-based techniques, fluoroscopy, MRI, and ultrasound guidance. Physicians use IR for procedures like angioplasty, stent placement, embolization, tumor ablation, and thrombectomy, making it a crucial tool in managing complex diseases without open surgery. The significance of this market lies in its ability to enhance patient outcomes while minimizing recovery time and costs. The advancements in artificial intelligence (AI), robotics, and augmented reality (AR) are transforming interventional radiology by improving imaging accuracy, automation, and procedural safety. The integration of AI in diagnostic imaging enhances decision-making, while robotic-assisted interventions improve precision, leading to better clinical outcomes. The expansion of outpatient surgical centers and the rise of hybrid operating rooms also contribute to the market's growth, as these facilities increasingly adopt IR techniques. The industries like biotechnology and medical device manufacturing play a critical role in advancing IR technologies, ensuring the continuous evolution of imaging systems, contrast agents, and catheter-based devices. Regulatory bodies like the FDA, CE, and ISO impose strict guidelines on product approval, sterility, and clinical validation to ensure safety and effectiveness, making compliance a crucial aspect of market entry and expansion.

According to the research report "Global Interventional Radiology Market Outlook, 2029," published by Bonafide Research, the Global Interventional Radiology market is anticipated to grow at more than 5.59% CAGR from 2024 to 2029. The growth of this sector is fueled by an increasing prevalence of cardiovascular diseases, cancer, and neurological disorders, leading hospitals, ambulatory surgical centers, and specialized clinics to adopt IR solutions for precise, image-guided treatments. The North American market dominates due to strong healthcare infrastructure and high adoption of advanced imaging technologies, while Asia-Pacific is witnessing rapid expansion with rising healthcare investments and medical tourism. Siemens Healthineers, GE Healthcare, Philips, and Medtronic lead the market with a portfolio of fluoroscopy systems, MRI-compatible catheters, and AI-driven imaging solutions. These companies focus on strategic collaborations, product innovation, and acquisitions to strengthen their presence. For instance, Philips has integrated AI-powered automated image reconstruction in its Azurion platform, while Medtronic emphasizes robotic-assisted vascular interventions to improve procedural efficiency. To differentiate, competitors invest in next-generation 3D navigation systems, real-time intravascular imaging, and cloud-based imaging analytics, enhancing precision and workflow automation. New product introductions, such as microcatheters, drug-eluting stents, and laser atherectomy devices, gain popularity in regions with high cardiovascular disease burdens, such as the United States and Europe. Governments and private institutions also support IR growth by launching vascular health awareness campaigns, thrombosis prevention programs, and oncology treatment subsidies to expand access.

Market Dynamics

Market Drivers

Rising Demand for Minimally Invasive Procedures The patients and healthcare providers preferring less invasive treatments, interventional radiology (IR) is growing rapidly. Procedures like angioplasty, embolization, and tumor ablation offer shorter recovery times, reduced hospital stays, and lower complication risks compared to traditional surgery.



Advancements in Imaging Technology The development of AI-powered imaging, robotic-assisted interventions, and 3D navigation systems enhances precision, accuracy, and real-time decision-making in IR. These innovations improve treatment outcomes and expand applications in oncology, cardiology, and neurology.

Market Challenges

High Equipment and Procedure Costs Advanced imaging systems like MRI-guided interventions, fluoroscopy, and cone-beam CT scanners are expensive, leading to cost constraints in hospitals, especially in developing regions. The high cost of consumables and skilled workforce requirements further limit widespread adoption.

Limited Skilled Workforce The growing demand for interventional radiologists outpaces the availability of trained professionals. Specialized training, certification requirements, and long learning curves create a talent gap, affecting the efficiency and accessibility of IR procedures worldwide.

Market Trends

AI Integration in Image-Guided Therapies AI-powered automated lesion detection, real-time image analysis, and predictive analytics are revolutionizing IR. These advancements enhance diagnostic accuracy, procedural efficiency, and treatment planning, making interventions more effective.

Expansion of IR in Outpatient Settings The shift toward ambulatory surgical centers (ASCs) and office-based labs (OBLs) for IR procedures is growing. This trend reduces hospital dependency, minimizes costs, and improves patient convenience, particularly for vascular and oncologic interventions.

Segmentation Analysis

Angiography systems are crucial in interventional radiology because they provide high-precision imaging for diagnosing and guiding minimally invasive procedures, particularly in cardiovascular and neurovascular interventions.

Angiography systems play a vital role in modern interventional radiology by offering real-time, high-resolution imaging that allows physicians to visualize blood vessels with exceptional clarity. These systems are extensively used to diagnose and treat conditions like arterial blockages, aneurysms, and vascular malformations without the need for open surgery. By injecting contrast media into the bloodstream, angiography systems help detect abnormalities that may not be visible on standard imaging techniques. Their significance is especially evident in cardiovascular care, where procedures such as angioplasty and stent placement rely on precise imaging to ensure optimal outcomes. In neurovascular applications, these systems assist in stroke management by guiding thrombectomy procedures, reducing complications and improving survival rates. The integration of digital subtraction angiography (DSA) enhances image quality by eliminating background noise, allowing clearer visualization of even the smallest vessels. With the increasing prevalence of cardiovascular diseases, demand for advanced angiography systems is growing, prompting manufacturers to develop innovations like flat-panel detectors, rotational angiography, and 3D imaging. These advancements improve diagnostic accuracy, reduce radiation exposure, and enhance procedural efficiency. The hybrid angiography suites combining CT, MRI, and fluoroscopy capabilities are gaining traction, enabling multidisciplinary treatment approaches within a single setting. The expansion of outpatient catheterization labs and office-based intervention centers has further boosted adoption, as angiography systems support a wide range of minimally invasive procedures with reduced hospital stays and faster recovery times. Governments and healthcare institutions worldwide are investing in these technologies to improve patient outcomes and streamlining workflow.

Cardiology holds a crucial position in interventional radiology because it relies on image-guided procedures to diagnose and treat life-threatening cardiovascular conditions with precision, reducing the need for open-heart surgeries and improving patient outcomes.

Interventional radiology has transformed cardiology by enabling minimally invasive procedures that enhance patient care while reducing recovery time and surgical risks. Physicians use advanced imaging techniques such as fluoroscopy, digital subtraction angiography, and intravascular ultrasound to visualize coronary arteries and cardiac structures in real time, making it possible to perform interventions with unparalleled accuracy. Procedures like angioplasty, stent placement, and catheter-based valve replacements have become standard treatments for coronary artery disease, a leading cause of mortality worldwide. These techniques allow doctors to restore blood flow to the heart without major incisions, significantly lowering complications and hospital stays. The demand for interventional cardiology procedures has surged with the rising prevalence of hypertension, diabetes, and sedentary lifestyles contributing to cardiovascular diseases. Technological innovations, such as bioresorbable stents, drug-eluting balloons, and robotic-assisted interventions, have further expanded treatment options, making procedures safer and more effective. Hybrid operating rooms combining interventional radiology with cardiac surgery enable multidisciplinary teams to manage complex cases with a seamless transition between imaging and intervention. The growing adoption of structural heart procedures, including transcatheter aortic valve replacement (TAVR) and percutaneous mitral valve repair, underscores cardiology's expanding role in interventional radiology. Hospitals and specialized cardiac centers continue to invest in state-of-the-art imaging equipment and catheterization labs to accommodate the increasing demand for minimally invasive cardiovascular treatments.

Hospitals play a vital role in the global interventional radiology market because they serve as primary centers for advanced image-guided procedures, offering comprehensive care, specialized equipment, and skilled medical professionals to handle a wide range of complex conditions.

Hospitals integrate interventional radiology into their healthcare systems to provide minimally invasive treatments for various medical conditions, from cardiovascular diseases and cancer to neurological disorders and trauma management. These institutions house high-end imaging technologies such as CT-guided intervention, MRI-compatible catheters, and digital fluoroscopy, ensuring real-time precision during procedures. The presence of multidisciplinary teams, including interventional radiologists, surgeons, and anesthesiologists, allows for seamless coordination in complex cases, improving patient safety and outcomes. Hospitals also handle a high volume of emergency cases, where interventional radiology is crucial for rapid interventions like embolization to control internal bleeding or thrombectomy to restore blood flow in stroke patients. With the increasing demand for personalized medicine, hospitals are expanding their interventional radiology departments to cater to targeted therapies such as radioembolization for liver cancer and cryoablation for tumors. The growing preference for outpatient procedures has led hospitals to establish dedicated interventional suites, reducing the need for extended hospital stays while maintaining high standards of care. Government funding and private investments are fueling the expansion of hospital infrastructure, enabling institutions to adopt robotic-assisted interventional systems and artificial intelligence-driven diagnostics, further improving procedural accuracy. Regulatory bodies enforce stringent quality and safety standards, ensuring that hospitals maintain the highest levels of patient care in interventional radiology.

Regional Analysis

North America dominates the global interventional radiology market due to its advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, strong presence of leading medical device manufacturers, and a well-established reimbursement system that supports minimally invasive procedures.

The region leads in interventional radiology because hospitals and diagnostic centers in the United States and Canada continuously upgrade to the latest imaging systems, ensuring precision in procedures such as angioplasty, embolization, and tumor ablation. The availability of state-of-the-art hybrid operating rooms, where interventional radiologists collaborate with surgeons, enhances treatment outcomes, particularly for cardiovascular and oncology patients. North America is home to major industry players like GE Healthcare, Siemens Healthineers, and Philips, who frequently introduce innovative products such as AI-driven imaging platforms and robotic-assisted intervention devices. The strong research ecosystem, backed by institutions like the Mayo Clinic and Johns Hopkins, accelerates the development of new interventional techniques and clinical trials, ensuring rapid adoption of breakthrough therapies. Government initiatives, such as the FDA’s streamlined approval process for interventional devices, make it easier for companies to introduce advanced solutions into the market. Additionally, the region has a high prevalence of chronic diseases, including coronary artery disease, stroke, and cancer, driving demand for minimally invasive treatments that offer quicker recovery times and lower procedural risks. The presence of a well-defined reimbursement system encourages hospitals and outpatient centers to invest in high-end interventional radiology equipment, making procedures more accessible to patients. The growing telemedicine integration allows remote consultations for interventional planning, expanding access to specialized care in rural areas.

Key Developments

• In June 2024, GE HealthCare and MediView XR Inc. announced the inaugural installation of the OmnifyXR interventional suite at North Star Vascular and Interventional (NSVI) in Minneapolis, Minnesota. This introduction signifies a substantial enhancement of the company's interventional radiology portfolio and is anticipated to enlarge their client base.
• In June 2024, Royal Philips announced the inaugural implantation of the Duo Venous Stent System, a device intended to address symptomatic venous outflow blockage in patients with chronic venous insufficiency (CVI), subsequent to its premarket clearance (PMA) from the U.S. Food and Drug Administration (FDA). This milestone is expected to improve the company's market reputation and fortify its industry position.
• In December 2024, AGFA HealthCare collaborated with Rad AI to transform radiology workflows. The partnership combines Rad AI Reporting and FHIRcast with AGFA's Enterprise Imaging platform, establishing a new standard in radiological innovation.
• In January 2023, Canon Medical Systems USA Inc. established a strategic agreement with ScImage, Inc. This collaboration merges Canon Medical's proficiency in diagnostic imaging with ScImage's cloud-based solutions for enterprise image management, PACS, and healthcare image exchange, hence providing improved functionalities to the healthcare industry.

Considered in this report
* Historic year: 2018
* Base year: 2023
* Estimated year: 2024
* Forecast year: 2029

Aspects covered in this report
* Interventional Radiology Market with its value and forecast along with its segments
* Country-wise Interventional Radiology Market analysis
* Various drivers and challenges
* On-going trends and developments
* Top profiled companies
* Strategic recommendation

By Product Type:
• MRI Systems
• Ultrasound Imaging Systems
• CT Scanners
• Angiography Systems
• Fluoroscopy Systems
• Biopsy Devices
• Other Products

By Application:
• Cardiology
• Urology and nephrology
• Oncology
• Gastroenterology
• Others

By End User:
• Hospitals
• Clinics
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analysing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to Interventional Radiology industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.